Metabolic Solutions Inc
Private Company
Total funding raised: $85M
Overview
Metabolic Solutions Inc. is a US-based, privately-held service provider specializing in stable isotope tracer analysis for metabolic research in drug development. Founded in 2006, the company offers an end-to-end solution from protocol design to submission-ready reports, leveraging over 35 years of collective expertise in the field. It serves as a critical partner for pharma and biotech companies, providing high-confidence, GLP-compliant data to validate mechanisms of action and make faster go/no-go decisions. The company operates from facilities in Nashua, NH, and Kalamazoo, MI, and is positioned as a niche, high-expertise CRO within the broader metabolic research landscape.
Technology Platform
Specialized stable isotope tracer analysis platform utilizing mass spectrometry to measure in vivo metabolic fluxes (e.g., glucose kinetics, protein turnover, collagen synthesis, cell proliferation) and non-invasive breath tests for organ function.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
MSI competes as a niche specialist against broad-service CROs and central labs that may offer some isotopic analysis but lack its depth and end-to-end service model. Its primary competitive advantage is over 35 years of focused expertise, regulatory-ready assays, and a partnership-oriented approach, differentiating it from generic vendors.